Market
Why precision fermentation, and why now
Market size
TAM · SAM · Wedge · SOM
TAM: global fermentation (USD), growing to $1.7T
SAM: cellular fermentation production (USD)
SOM: NOVAKERN 2032 revenue (EUR)
Wedge: $1.5–3B premium cosmetics bioactives
The beachhead we land first: direct sales, LOIs signed, today → 2028.
TAM / SAM / Wedge: global market, USD. SOM: NOVAKERN 2032 revenue, EUR. Deck figures.
The problem with conventional fermentation
$420B
Specialty ingredients still sourced the old way
A $420B specialty-ingredients industry still depends on animal extraction and crop processing: methods whose yield and purity are set by biology and weather rather than by process control.
±40%
Input prices swing with harvests and herds
Buyers of functional proteins routinely absorb double-digit annual price swings driven by drought, herd size and export policy. Procurement cannot forecast, and reformulation is expensive.
Batch-to-batch
Specification drifts at volume
Extracted inputs vary by source, season and lot. Formulators compensate with over-engineering and wider tolerances, which pushes cost into every downstream product.
High-value
The best actives are the hardest to source
The highest-value functional proteins and enzymes command premium prices in cosmetics, nutraceuticals and processing, yet are precisely the ones hardest to obtain at consistent quality and scale.
One platform, expanding markets
Each layer runs on the same continuous-production platform
Why now
Manufacturers now require animal-free supply
Animal-free sourcing has moved from a marketing claim to a procurement requirement across European food, cosmetics and personal-care brands. Buyers need a qualified, documented, non-extractive supply, and very few exist at industrial specification.
Premium beauty wants functional actives
Skincare is the value centre of a global beauty market heading past $680B by 2030, and functional proteins are established actives within it. Cosmetic-grade ingredients clear a shorter approval path than food, which makes them the fastest first route to revenue.
Plant alternatives added a category, not a specification
Plant-derived substitutes created a category but did not solve specification: they cannot reproduce the exact protein structures formulators actually specify. Precision fermentation targets the molecule itself rather than an approximation of it.
Continuous production changes the economics
Running at steady state rather than in discrete batches is what moves unit cost from premium-niche toward commodity-adjacent. It is also what turns the process into something a manufacturer would rather license than rebuild, which is the second engine.
Competitive landscape
- Incumbent · low unit cost · variable purity
Animal Extraction
The default source for most functional proteins today. Cheap at volume and deeply embedded in supply chains, but specification drifts by source and season, and animal-free mandates are progressively closing it off.
- Mature · moderate cost · non-animal
Plant Extraction
Solves the animal-free requirement but not the specification problem: yield and profile move with crop, harvest and region, and the exact protein structures formulators specify often cannot be obtained at all.
- Batch campaigns · high unit cost · scale-limited
Batch Fermentation Peers
Correct molecule, right approach, but produced in discrete campaigns. Capital per kilogram stays high, changeovers cost yield, and unit economics plateau well above the point where large manufacturers switch.
- Continuous platform · €180/kg → <€60/kg · two engines
NOVAKERN
Continuous rather than batch production, which is what moves cost per kilogram far enough to convert volume buyers. The same process is then licensed to manufacturers who would rather adopt it than rebuild it, turning the cost curve into a second revenue engine.
NOVAKERN competes on process rather than on molecule. Peers can express the same proteins; almost all of them do it in batch campaigns, which caps throughput per litre of installed capacity and holds capital per kilogram high. Running continuously at steady state is what carries unit cost from roughly €180/kg at pilot scale toward under €60/kg at industrial scale. Commercially, cosmetic-grade actives clear a shorter qualification cycle than food, so revenue starts on the high-margin beachhead while food-enzyme dossiers move through the longer EU authorisation route in parallel. From 2028 the licensed platform becomes the larger of the two engines.